Solve FSHD
North America, British Columbia, Canada, Vancouver
Description
Solve FSHD fosters innovation and accelerates critical research toward a treatment for facioscapulohumeral muscular dystrophy.
Investor Profile
Solve FSHD has backed more than 4 startups, with 3 new investments in the last 12 months alone. The firm has led 3 rounds, about 75% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Seed, Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States, Japan.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 2 rounds in the past year.
Stage Focus
- Series B (50%)
- Seed (25%)
- Post Ipo Equity (25%)
Country Focus
- United States (75%)
- Japan (25%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Biopharma
- Health Diagnostics
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
